- Home
- TTGT vs LXRX Comparison
TTGT vs LXRX Comparison
Compare TTGT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTGT
- LXRX
- Stock Information
- Founded
- TTGT 1999
- LXRX 1995
- Country
- TTGT United States
- LXRX United States
- Employees
- TTGT N/A
- LXRX N/A
- Industry
- TTGT Telecommunications Equipment
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- TTGT Telecommunications
- LXRX Health Care
- Exchange
- TTGT Nasdaq
- LXRX Nasdaq
- Market Cap
- TTGT 810.0M
- LXRX 650.7M
- IPO Year
- TTGT 2007
- LXRX 2000
- Fundamental
- Price
- TTGT $29.01
- LXRX $0.98
- Analyst Decision
- TTGT Strong Buy
- LXRX Buy
- Analyst Count
- TTGT 6
- LXRX 2
- Target Price
- TTGT $38.17
- LXRX $6.00
- AVG Volume (30 Days)
- TTGT 141.0K
- LXRX 4.3M
- Earning Date
- TTGT 11-12-2024
- LXRX 11-12-2024
- Dividend Yield
- TTGT N/A
- LXRX N/A
- EPS Growth
- TTGT N/A
- LXRX N/A
- EPS
- TTGT N/A
- LXRX N/A
- Revenue
- TTGT $226,314,000.00
- LXRX $5,229,000.00
- Revenue This Year
- TTGT $2.45
- LXRX $1,212.46
- Revenue Next Year
- TTGT $8.79
- LXRX $219.10
- P/E Ratio
- TTGT N/A
- LXRX N/A
- Revenue Growth
- TTGT N/A
- LXRX 886.60
- 52 Week Low
- TTGT $22.82
- LXRX $0.97
- 52 Week High
- TTGT $41.93
- LXRX $3.73
- Technical
- Relative Strength Index (RSI)
- TTGT 50.90
- LXRX 25.78
- Support Level
- TTGT $28.68
- LXRX $1.01
- Resistance Level
- TTGT $33.12
- LXRX $1.35
- Average True Range (ATR)
- TTGT 1.35
- LXRX 0.12
- MACD
- TTGT -0.12
- LXRX -0.06
- Stochastic Oscillator
- TTGT 20.35
- LXRX 0.43
About TTGT TechTarget Inc.
TechTarget Inc is a data, software and analytics leader for purchase intent-driven marketing and sales data which delivers business impact for business-to-business (B2B) companies. The company solutions are designed to enable B2B technology companies to identify, reach, and influence key enterprise technology decision makers faster and with higher efficacy. Geographically, it derives a majority of its revenue from North America. Its products and services intended to improve information technology vendors abilities to impact targeted audiences for business growth using targeting, first-party analytics and data services complemented with customized marketing programs that integrate content creation, demand generation, brand marketing, and other advertising techniques.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.